Clinical Trials Browser

Phase NA × camrelizumab × Thoracic × Clear all

NCT05532527 2022-09-08

NSCLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT04950400 2021-07-06

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung